This phase IV trial is trying to determine if giving an iron infusion to iron-deficient colorectal cancer patients who are anaemic versus not anaemic will improve their physical fitness for planned surgery.
This trial is treating patients with colorectal cancer.
This is a treatment trial.
You may be excluded from this trial if:
- You have a certain disease or psychological condition.
Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.
Clinical Summary Read More
Use the hyperlinks, where available to access additional clinical trial information.
An iron infusion with Ferric Carboxymaltose as a technique of improving physiological reserve in iron deficient patients undergoing surgery for colorectal cancer: a randomized control trial
Other Non-Commercial Sponsor
Peter MacCallum Cancer Centre
Eligible patients will be randomly (by chance) allocated to receive an infusion enriched with 1000mg iron (Ferric Carboxymaltose) OR a saline solution of similar appearance. All participants will receive maximum of 250mls of 0.9% saline solution with or without iron (depending on group) over a 15 minute period. All patients will be monitored for 30 minutes following completion of the infusion. No further blood tests will be required on the day of the infusion.
Recruiting Hospitals Read More
Not Recruiting Hospitals Read More